US Stock MarketDetailed Quotes

IPHYF INNATE PHARMA

Watchlist
  • 2.490
  • 0.0000.00%
15min DelayClose Jun 18 09:30 ET
201.56MMarket Cap-25670P/E (TTM)

INNATE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INNATE PHARMA Earnings Date

Currency: EUR

Period

FY2023 Annual Report

--

Revenue(YoY)

51.90M

+4.68%
EPS(YoY)

-0.09

+87.67%
Analyst Rating

Hold

Jun 19, 2024

INNATE PHARMA Earnings Estimates

Revenue

EPS

EBIT

No Data

INNATE PHARMA Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 14 18:10

  • INNATE PHARMA | 20-F: Registration statement / Annual report / Transition report

    Apr 4 20:10

    • Analysis

    Analyst Rating

    Updated: Jun 19, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg